Top Markets
Coin of the day
Bio Preventive Medicine Corp. Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp.

6810
Rank in Stocks #27178
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
Share Price
$0.70116857
Market Cap
$34.67M
Change (1 day)
-1.78%
Change (1 year)
-18.30%
Country
TW
Trade Bio Preventive Medicine Corp. (6810)

Category

Earnings for Bio Preventive Medicine Corp. (6810)
Earnings in 2026 TTM: 0
According to Bio Preventive Medicine Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Bio Preventive Medicine Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$-3.09B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH